Assault by other and unspecified firearm discharge

VWXY20_ASSAU_OTHER_UNSPE_FIREA_DISCH

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — X95 Cause of death: ICD-10 — X95 2 out of 7 registries used, show all original rules.	61
4. Check minimum number of events None	61
5. Include endpoints None	61
6. Filter based on genotype QC (FinnGen only)	61

Control definitions (FinnGen only)

Control exclude: VWXY20_ASSAULT

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: X85-Y09

NAME	VWXY20_ASSAU_OTHER_UNSPE_FIREA_DISCH
CONTROL_EXCLUDE	VWXY20_ASSAULT
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	X95
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	X95
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Assault by other and unspecified firearm discharge based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	61	16	45
Unadjusted period prevalence (%)	0.02	0.01	0.02
Median age at first event (years)	41.59	40.82	41.86

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
51: Matched controls
510

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

X95.9

ICD-10 Finland

Assault by other and unspecified firearm discharge by unknown person

+∞

25.1

X95.0

ICD-10 Finland

Assault by other and unspecified firearm discharge by spouse or partner

+∞

21.3

X95.8

ICD-10 Finland

Assault by other and unspecified firearm discharge by other known person

+∞

11.9

N05AH04

ATC

quetiapine; oral

6.5

7.1

JAH00

NOMESCO Finland

Laparotomy

46.4

7.0

ZXA00

NOMESCO Finland

Right side

6.3

6.7

N05BA01

ATC

diazepam; systemic, rectal

7.3

6.5

X58

ICD-10 Finland

Exposure to other specified factors

6.7

6.5

T36

ICD-10 Finland

Poisoning by systemic antibiotics

12.4

6.4

Y04.9

ICD-10 Finland

Assault by bodily force by unknown person

+∞

6.4

N05BA04

ATC

oxazepam; oral

5.1

6.2

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3028707) Methadone [Presence] in Urine by Screen method

13.20

10.46

3.9

2.4

—

(3011288) Drugs identified in Urine by Screen method

10.43

9.69

6.0

2.1

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

174

4.14

6.85

8.6

5.2

34.4

37.5

g/l

1.78

165

(3023368) Bacteria identified in Blood by Culture

117

4.08

6.79

9.6

4.8

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

7.24

6.68

3.9

1.9

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

121

3.91

6.40

2.0

1.9

98.6

93.3

pmol/l

0.23

(3042936) Bacteria identified in Isolate by Culture

4.40

5.85

3.9

1.8

—

(3000764) Benzodiazepines [Presence] in Urine

5.73

5.77

3.8

1.7

—

(3028300) Cannabinoids [Presence] in Urine

5.50

5.53

3.8

1.7

—

(3027008) Opiates [Presence] in Urine

5.50

5.53

3.8

1.7

—

(3027944) Amphetamines [Presence] in Urine

5.50

5.53

2.3

1.7

—

(3016879) Cocaine [Presence] in Urine

5.50

5.53

3.8

1.6

—

(3007853) Bacteria identified in Skin by Aerobe culture

4.06

5.28

2.7

1.6

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

134

2.82

3.72

2.7

2.1

333.1

237.1

u/l

0.19

129

(3013115) Eosinophils [#/volume] in Blood

227

2.79

3.64

8.6

8.8

0.2

e9/l

0.23

200

(42870588) Differential panel, method unspecified - Blood

144

2.75

3.58

7.4

7.1

—

(3006315) Basophils [#/volume] in Blood

224

2.66

3.36

7.9

8.0

0.0

e9/l

0.04

195

(3001604) Monocytes [#/volume] in Blood

224

2.66

3.36

7.9

8.0

0.6

e9/l

0.02

194

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2.82

3.24

4.9

2.8

14.1

30.8

ng/l

0.65

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

3.93

3.20

2.0

1.6

—

(3026008) Bacteria identified in Urine by Culture

2.83

3.18

4.0

2.3

—

(3019198) Lymphocytes [#/volume] in Blood

229

2.56

3.14

8.0

8.2

2.0

1.8

e9/l

0.82

201

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

106

2.68

3.13

1.8

1.6

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

10.72

3.03

1.2

1.4

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

139

2.52

2.98

2.7

1.9

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2.70

2.82

2.9

1.8

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

6.51

2.76

1.7

1.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

2.66

2.75

3.2

2.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

7.64

2.59

1.2

1.1

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

262

2.35

2.58

12.7

11.9

4.4

4.3

e9/l

0.03

229

(3012516) Albumin [Mass/volume] in Urine

102

2.43

2.47

3.6

3.5

3687.4

57.3

mg/l

0.48

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

4.50

2.44

9.6

7.3

—

(3012544) pH of Venous blood

2.98

2.33

4.6

4.8

—

(3044290) Cell count panel - Cerebral spinal fluid

4.99

2.33

2.5

1.8

—

(3020682) Albumin/Creatinine [Ratio] in Urine

106

2.32

2.25

5.0

4.3

18.7

10.0

mg/mmol

0.28

(3044889) 12 lead EKG panel

324

2.28

2.17

3.1

3.3

—

(3022948) Iron [Moles/volume] in Serum or Plasma

2.63

2.15

4.0

2.7

12.0

14.7

umol/l

0.59

(3017143) Hepatitis C virus Ab [Presence] in Serum

2.35

2.11

1.6

1.8

—

(3015736) pH of Urine

184

2.10

2.08

3.3

3.2

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

3.62

2.03

7.9

1.9

117.4

113.7

ng/l

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

168

2.09

2.02

4.0

3.0

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

4.04

1.99

2.2

1.6

421.7

527.8

mg/l

—

(3002582) Erythrocytes [#/volume] in Urine

148

2.02

1.81

4.5

2.8

25.5

23.7

e6/l

0.03

111

(3018095) Leukocytes [#/volume] in Urine

166

1.99

1.77

5.3

3.4

25.7

21.2

e6/l

0.14

116

(3019225) pH of Specimen

2.81

1.73

4.1

2.6

—

(3004588) Protein electrophoresis panel - Serum or Plasma

3.03

1.70

1.1

4.0

—

(3032080) INR in Blood by Coagulation assay

168

1.95

1.70

10.8

7.5

1.2

inr

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

2.12

1.69

3.7

2.2

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2.38

1.68

3.7

1.6

—

(3002385) Erythrocyte distribution width [Ratio]

418

2.34

1.67

29.4

14.3

13.8

13.5

0.86

413

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

3.21

1.62

2.3

2.8

5.3

5.1

kpa

—

(3037467) Urinalysis macro (dipstick) panel - Urine

313

1.95

1.60

5.2

3.8

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

3.53

1.55

2.0

1.4

3.5

3.7

mmol/l

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

3.53

1.55

1.6

1.5

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

401

2.13

1.52

4.3

3.2

—

(3013512) EKG study

2.02

1.51

4.1

3.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

2.53

1.51

3.3

2.6

—

(3019060) Gas panel - Arterial blood

2.69

1.50

3.0

4.7

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

2.31

1.49

1.1

1.7

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

3.31

1.47

1.0

3.3

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2.20

1.44

3.5

1.8

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

495

2.60

1.44

30.2

11.7

21.5

22.5

mg/l

0.10

384

(3021589) Normoblasts [#/volume] in Blood

203

1.82

1.44

13.4

9.8

0.0

e9/l

0.50

167

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

2.06

1.39

3.6

2.4

6.4

1.7

e6/l

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

3.11

1.38

2.0

1.9

0.5

0.0

e6/l

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

2.48

1.33

3.3

2.5

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

2.93

1.31

1.2

1.3

—

(3000991) Gas panel - Venous blood

2.40

1.30

10.8

7.5

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

2.55

1.27

1.3

—

(3030467) Casts [#/volume] in Urine by Automated count

138

1.80

1.25

4.7

2.9

0.0

0.3

e6/l

1.60

100

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

192

1.73

1.23

6.0

3.7

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2.45

1.22

2.2

1.2

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

167

1.72

1.17

4.4

2.7

12.5

22.3

ng/l

1.64

101

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

108

1.80

1.12

1.8

1.6

—

(3022145) Colonoscopy Study observation

2.07

1.08

1.2

1.3

—

(3026493) Urate [Moles/volume] in Serum or Plasma

144

1.70

1.06

1.8

2.5

352.2

3538.0

umol/l

0.50

129

(44816559) Phosphatidylethanol [Mass/volume] in Blood

2.38

1.05

1.8

1.4

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2.38

1.05

10.0

5.7

24.8

25.8

mmol/l

—

(3001019) Free T4 and TSH panel - Serum or Plasma

0.00

0.99

0.0

2.1

—

(3027945) Reticulocytes/100 erythrocytes in Blood

2.00

0.97

1.7

2.5

1.7

—

(40758558) Short blood count panel - Blood

113

1.70

0.95

15.8

7.4

—

(36304419) Bacteria [Presence] in Urine

140

1.64

0.93

4.7

2.8

—

(3002256) Pathology report gross observation

1.77

0.82

1.1

1.2

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

118

1.61

0.80

1.5

1.7

1.5

1.6

mmol/l

0.16

101

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

2.18

0.76

2.8

3.2

1.1

2.0

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1.90

0.75

4.0

2.7

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

2.09

0.74

1.2

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1.65

0.73

3.6

2.4

0.8

e6/l

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

1.80

0.73

1.4

2.2

34.1

35.3

nmol/l

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

157

1.51

0.72

3.1

2.7

71.7

76.3

nmol/l

0.21

145

(3004119) Hemoglobin [Mass/volume] in Venous blood

1.85

0.68

2.8

4.3

134.6

131.8

g/l

—

(3025941) Bacteria identified in Stool by Culture

1.79

0.65

1.0

1.2

—

(1761868) Lipid panel - Serum or Plasma

237

0.71

0.53

2.6

2.5

—

(3003694) ABO and Rh group [Type] in Blood

129

0.65

0.50

1.4

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

449

1.46

0.49

5.7

4.3

38.4

mmol/mol

0.00

425

(4010399)

1.61

0.43

1.0

1.3

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1.49

0.42

2.5

1.8

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

464

1.43

0.42

20.8

10.2

97.5

89.9

ml/min/173m2

1.63

395

(4034850)

0.00

0.42

0.0

22.5

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

0.00

0.42

0.0

1.5

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

0.00

0.42

0.0

1.7

—

(36660697) Celiac disease serology panel - Serum

1.40

0.35

1.3

1.2

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1.33

0.29

5.3

2.2

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

0.66

0.28

1.2

1.5

—

(40760892) CBC W Ordered Manual Differential panel - Blood

124

1.28

0.27

3.5

5.8

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1.24

0.22

4.2

3.8

31.8

30.2

—

(4268621)

0.00

0.21

0.0

2.1

—

(4306422)

0.00

0.21

0.0

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

0.00

0.21

0.0

1.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

0.00

0.21

0.0

1.6

—

157.2

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.6

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

0.00

0.21

0.0

1.1

—

8.9

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

0.00

0.21

0.0

1.2

—

(3035350) Ketones [Presence] in Urine by Test strip

245

1.18

0.20

4.6

3.3

0.0

estimate

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

0.00

0.20

0.0

1.1

—

1.0

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1.17

0.20

19.8

11.8

—

(3000492) Spirometry study

1.17

0.18

1.4

1.3

—

(40768804) Tissue Pathology biopsy report

161

1.17

0.15

2.1

1.7

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

192

1.14

0.13

4.4

3.2

—

(3044640) Blood type and Crossmatch panel - Blood

134

1.16

0.12

7.1

2.1

—

(3041096) Erythrocytes [Presence] in Urine by Automated

144

1.15

0.12

4.5

2.3

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1.15

0.09

1.0

2.6

306.5

403.4

nmol/l

—

(40768797) Stomach Pathology biopsy report

0.80

0.08

1.4

1.2

—

(3021601) Nitrite [Presence] in Urine by Test strip

246

1.10

0.08

6.5

4.3

0.0

estimate

—

(3029937) Albumin [Presence] in Urine by Test strip

130

0.90

0.05

5.7

3.9

0.0

estimate

—

(3009261) Glucose [Presence] in Urine by Test strip

250

1.07

0.04

4.7

3.3

0.0

estimate

—

(3009542) Hematocrit [Volume Fraction] of Blood

499

0.91

0.04

29.5

12.0

41.9

42.7

0.52

422

(3011397) Hemoglobin [Presence] in Urine by Test strip

114

1.07

0.01

4.0

—

(3022806) Fractional oxyhemoglobin in Capillary blood

0.00

0.0

1.5

—

88.5

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.00

0.0

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.7

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.7

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

0.00

0.0

1.0

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

0.00

0.0

1.0

—

194.9

—

(3045424) Erythrocytes [Presence] in Urine

0.00

0.0

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.7

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

0.00

0.0

1.1

—

(3035637) Corticotropin [Mass/volume] in Plasma

0.00

0.0

1.3

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.7

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

0.00

0.0

1.3

—

573.0

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

0.00

0.0

1.7

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.7

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

0.00

0.0

2.0

—

13.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.7

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

251.7

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

0.00

0.0

7.7

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

0.00

0.0

1.2

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

0.00

0.0

1.0

—

(3029075) Extractable nuclear Ab panel - Serum

0.00

0.0

1.0

—

(40768795) Lymph node Pathology biopsy report

0.00

0.0

1.0

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

0.00

0.0

3.7

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.00

0.0

2.0

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

0.00

0.0

1.0

—

(21494890) Protein electrophoresis panel - 24 hour Urine

0.00

0.0

5.4

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

0.00

0.0

1.1

—

(3023420) DNA double strand Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

0.00

0.0

1.4

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

0.90

0.00

1.6

1.4

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

0.00

0.0

2.2

—

3.3

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

0.00

0.0

2.9

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

0.00

0.0

1.7

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

0.00

0.0

4.4

—

12.8

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: VWXY20_ASSAU_OTHER_UNSPE_FIREA_DISCH – Assault by other and unspecified firearm discharge

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Assault by other and unspecified firearm discharge

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Assault by other and unspecified firearm discharge (VWXY20_ASSAU_OTHER_UNSPE_FIREA_DISCH)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints